You just found out your son needs treatment. Or your daughter. Or your spouse. Maybe you have known for a while, but now it is real, and someone needs to go somewhere, and you have 72 hours to figure out where.
So you start Googling. And within ten minutes you are drowning. Thousands of facilities. Glossy websites. Stock photos of people meditating on beaches. Everyone claims to be “the best.” Everyone promises transformation. And you have no idea how to tell the difference between a program that will actually help and one that is just good at marketing.
Here is what we tell every family that calls us: slow down just enough to ask the right questions. You do not need to become an expert in addiction medicine overnight. But you do need to know what separates a quality treatment center from one that will waste your time, your money, and your loved one’s willingness to try.
Start With the Right Level of Care
Before you compare treatment centers, you need to understand that “treatment” is not one thing. It is a spectrum, and the right starting point depends on the individual, not on what is available or what is cheapest.
The American Society of Addiction Medicine (ASAM) Criteria defines a continuum that ranges from outpatient services (a few hours per week, living at home) through intensive outpatient and partial hospitalization programs, up to full residential/inpatient care and hospital-level medically managed treatment. Where someone lands on that continuum should be determined by a clinical assessment across six dimensions: withdrawal risk, medical conditions, mental health, readiness to change, relapse potential, and the person’s living environment. A reputable facility will assess all six before recommending a level of care.
Red flag: A center that recommends the same level of care to every caller, regardless of circumstances, is selling beds, not providing clinical guidance. If the first call feels more like a sales pitch than an intake assessment, keep looking.
The 30 vs. 60 vs. 90 Day Question
Families almost always ask: “How long does treatment need to be?” And the honest answer is that it depends. But there is a floor, and the research is clear about where it sits.
The Drug Abuse Treatment Outcome Studies (DATOS), one of the largest longitudinal studies of treatment outcomes ever conducted, followed clients across 96 U.S. treatment programs. At five-year follow-up, clients who stayed in residential treatment for 90 days or longer had significantly better outcomes than those who left earlier. Stays of six months or more in long-term residential care were associated with even greater reductions in substance use (Hubbard et al., 2003).
This is why NIDA’s recommendation of a minimum 90-day treatment duration exists. It is not arbitrary. It is grounded in decades of outcome data.
Does that mean 30 days is useless? No. But it means 30 days is often stabilization, not treatment. The person detoxes, starts therapy, begins to feel better, and then walks back into the exact environment that fueled the problem. Thirty days can be a critical first step. It is rarely enough on its own.
A quality treatment center will recommend length of stay based on clinical need. If a facility is pushing the shortest possible stay because that is what insurance will cover without a fight, that tells you something about their priorities. Insurance limits are real, but a good program will advocate for extensions when the clinical picture calls for it.
What the Research Actually Says About Effective Treatment
The National Institute on Drug Abuse has published 13 research-based principles that define effective addiction treatment. A meta-analysis tested seven of those principles across multiple controlled studies and confirmed that five hold up to rigorous scrutiny (Pearson et al., 2012). These are not opinions. They are validated findings.
Here are the ones that matter most when you are evaluating a facility:
Treatment must be individualized. No single approach works for everyone. If a center runs every client through the same 28-day track with the same groups, the same schedule, and the same discharge plan, that is a program built for operational convenience, not for the person in front of them.
Multiple needs must be addressed. Substance use rarely exists in isolation. Depression, anxiety, trauma, ADHD, eating disorders, chronic pain. A quality program screens for co-occurring conditions and treats them simultaneously. Ask directly: “Do you have licensed mental health professionals on staff? How do you handle dual diagnosis?”
The treatment plan must be reassessed continuously. Recovery does not follow a straight line. Someone may arrive needing detox and stabilization, then transition into trauma work, then need vocational support. The plan should evolve. Ask: “How often do you reassess the treatment plan? Who is involved in those decisions?”
Medication-assisted treatment should be available when appropriate. For opioid use disorders in particular, medications like buprenorphine and naltrexone significantly improve outcomes. Any center that refuses to consider MAT on ideological grounds is ignoring the evidence. This is not about philosophy. It is about what works.
The Accreditation Question Most Families Never Ask
Here is a statistic that surprises most families: only about 22% of addiction treatment facilities in the United States hold CARF accreditation, and roughly 19% hold Joint Commission accreditation (SAMHSA N-SSATS, 2020). That means the majority of treatment centers nationwide operate without any nationally recognized accreditation.
State licensing is the bare minimum. It means the facility met the legal requirements to operate. It does not mean the facility delivers quality care. National accreditation from the Joint Commission or CARF is voluntary, rigorous, and involves ongoing review of clinical practices, safety protocols, and outcomes measurement. Accredited facilities demonstrated a 37% increase in quality standards compliance after achieving accreditation.
What to do: Ask every facility you are considering whether they hold Joint Commission or CARF accreditation. Then verify it yourself. Both organizations have online directories. Do not take the facility’s word for it.
This single question will eliminate a significant percentage of low-quality programs from your list.
The Aftercare Problem Nobody Talks About
Here is where most treatment centers fail families, and where most families do not know to look.
A person completes 60 or 90 days of residential treatment. They are stable, engaged, maybe even optimistic. The facility hands them a discharge summary, a list of outpatient providers, and a schedule of local 12-step meetings. Maybe they get a follow-up phone call. Maybe they do not. And then they are on their own.
This is the treatment cliff. And it is where a staggering number of people relapse.
Research on continuing care is unambiguous: programs that produce lasting results share three features. They plan for a longer duration of continuing care. They deliver more intensive post-treatment services. And they actively reach out to clients rather than waiting for clients to show up (McKay, 2009). Passive aftercare, the “here’s a list, good luck” approach, consistently underperforms.
During your evaluation, ask these questions:
- “What does your aftercare plan look like?”
- “How long does structured follow-up last?”
- “Do you actively contact clients after discharge, or do you wait for them to reach out?”
- “Do you coordinate with outpatient providers, sober living, and family supports?”
If the answer to any of these is vague, that is a problem. A treatment center that does not plan for what happens after treatment is only doing half the job.
This is also where professional case management becomes critical. Someone needs to be coordinating between providers, tracking progress, adjusting the plan, and keeping the family informed. That role does not fill itself.
Red Flags That Should Stop You Cold
The addiction treatment industry has a fraud problem. It is not a secret. In 2017, Congress held hearings on patient brokering and treatment fraud that documented alarming practices: brokers being paid $500 to $5,000 per person recruited into treatment, facilities billing thousands of dollars daily for unnecessary urine drug tests, and in the worst cases, brokers providing drugs to individuals to trigger relapse so they could be re-enrolled and re-billed (U.S. Congress Hearing, Serial No. 115-86, 2017).
The rapid expansion of insurance coverage for addiction treatment, a positive development in itself, created financial incentives that attracted bad actors alongside legitimate providers (Garrido et al., 2022).
Here are the red flags that should make you walk away:
Someone offers to pay for travel or housing to get your loved one to a specific facility. This is patient brokering. It is illegal in most states, and it means someone is getting paid a referral fee for sending your family member there.
The facility offers to help enroll your loved one in an insurance plan. Legitimate treatment centers verify existing insurance. They do not sign people up for new plans, especially at inflated premiums, to maximize billing.
You are pressured to decide immediately. “We have one bed left and it will be gone by tomorrow.” This is a sales tactic. Quality treatment programs exist. There is no scenario where your only option is the one being sold to you under a countdown clock.
The facility guarantees results. No ethical provider promises a cure. A landmark paper in JAMA established that addiction is a chronic illness comparable to diabetes, hypertension, and asthma, with relapse rates of roughly 40-60%, similar to hypertension (50-70%) and asthma (50-70%) (McLellan et al., 2000). We do not say a diabetic’s treatment “failed” because their blood sugar spiked. We adjust the plan. The same applies here. Any program that guarantees sobriety is either lying or does not understand the condition they claim to treat. Recovery is an ongoing process, and the right center builds long-term management into the plan from day one.
The marketing feels like a resort brochure. Infinity pools, gourmet meals, equine therapy, surf lessons. These things are not treatment. They might make the experience more comfortable, but they are not what produces recovery. If the website spends more space on amenities than on clinical programming, that tells you where their investment went.
The first conversation is about money, not about the person. A clinical intake should start with questions about the individual: what substances, how long, what has been tried before, co-occurring mental health conditions, family dynamics, living situation. If the first ten minutes are about your insurance card and your credit card, you are talking to a billing department, not a treatment team.
What to Actually Ask During the Evaluation Call
When you call a treatment center, you are conducting a job interview. They are applying to take care of your family member. Treat it that way.
Here is a practical list:
- “Are you accredited by the Joint Commission or CARF?” Verify independently.
- “How do you determine the appropriate level of care?” Listen for mention of ASAM Criteria or a comparable clinical assessment tool.
- “What is your clinical staff-to-client ratio?” Lower ratios mean more individual attention.
- “How do you handle co-occurring mental health conditions?” “We refer out” is a weaker answer than “We have licensed clinicians who treat both simultaneously.”
- “What is your policy on medication-assisted treatment?” “We don’t believe in it” is a disqualifying answer for most clinical scenarios.
- “What does your aftercare plan include, and how long does it last?” The stronger the answer here, the better the program.
- “What are your actual completion rates?” Not “success rates,” which means different things to different programs. Completion rates are more objective.
- “How do you communicate with families during treatment?” Weekly updates, family therapy sessions, and clear escalation protocols are signs of a program that treats the whole system.
Why Families Hire a Navigator
Most families making this decision have never done it before. They do not know the industry. They do not know the questions. They do not know how to verify what they are being told. And they are doing all of this while terrified.
This is why families bring in someone who does this work every day.
At ORCA, part of what we do is help families evaluate and select treatment centers that match the clinical needs of their loved one, not the marketing budget of the facility. We know which programs deliver on their promises and which ones do not. We have placed people in programs across the country and tracked what happened afterward. That pattern recognition matters.
We also stay involved after placement. Through ongoing case management and coordination, we make sure the transition from treatment back to real life does not happen in a vacuum. The first 90 days after treatment are the most fragile period, and they deserve the same level of planning and attention as the treatment itself.
If your family is facing this decision right now, you do not have to figure it out alone. An intervention paired with informed placement and long-term follow-through is not just a better approach. For many families, it is the difference between another failed attempt and the beginning of real change.
Ask the hard questions. Verify the answers. And do not let urgency override diligence. Your loved one deserves a program that was chosen with care, not panic.
